The effects of telomerase inhibitors on lymphocyte function

Anticancer Research

Volumn 19, Issue 4 B, 1999, Pages 3205-3211

  Beltz, Lisa A ^a   Moran, Robert ^b   Elsawy, Osama ^a   Sadler, Jeffrey ^a   Jurgenson, James ^a  

^a UNIVERSITY OF NORTHERN IOWA   (United States)

^b DES MOINES UNIVERSITY   (United States)

Author keywords

Immunosuppression; Oligonucleotides; Reverse transcriptase inhibitors; Telomerase

Indexed keywords

DIDANOSINE; ENZYME INHIBITOR; OLIGONUCLEOTIDE; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; TELOMERASE; TELOMERASE INHIBITOR; UNCLASSIFIED DRUG; ZIDOVUDINE;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL;

CELL CYCLE; CELL DIVISION; ENZYME INHIBITORS; HUMANS; LYMPHOCYTES; TELOMERASE; TUMOR CELLS, CULTURED;

EID: 0033404085     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Blackburn EH and Gall JG: A tandemly repeated sequence at the termini of the extrachromosomal ribosomal RNA genes in Tetrahymena. J Mol Biol 120: 33-53, 1978.
2. Szostak JW and Blackburn EH: Cloning yeast telomeres on linear plasmid vectors. Cell 29: 245-255, 1982.
3. Cooke HJ, Brown WRA and Rappold GA: Hypervariable telomeric sequences from the human sex chromosomes are psuedoautosomal. Nature 317: 687-692, 1985.
4. Moyis RK, Buckingham JJ, Cram LS, Dani M, Deaven LT, Jones MD, Meyne J, Ratliff RL and Wu J-R: A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. Proc Natl Acad Sci USA 85: 6622-6626, 1988.
5. de Lange T: Activation of telomerase in a human tumor. Proc Natl Acad Sci USA 91: 2282-2285, 1994.
6. Greider CW: Mammalian telomere dynamics: healing, fragmentation shortening and stabilization. Curr Opin Genet Develop 4: 203-211, 1994.
7. Levy MZ, Allsopp RC, Futcher AB, Greider CW and Harley CB: Telomere end-replication problem and cell aging. J Mol Biol 225: 951-960, 1992.
8. Allsopp RC, Vaziri H, Patterson C, Goldstein S, Youngali EV, Futcher AB, Greider CW and Harley CB: Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA 89: 10114-10118, 1992.
9. Norrback K-F and Roos G: Telomeres and telomerase in normal and malignant hematopoietic cells. Eur J Cancer 33: 774-780, 1997.
10. Harley CB, Kim NW, Prowse KR, Weinrich SL, Hirsch KS, West MD, Bacchetti S, Hirte HW, Counter CM, Greider CW, Platyszek MA, Wright WE and Shay JW: Telomerase, cell immortality, and cancer. Cold Spring Harb Symp Quant Biol 59: 307-315, 1994.
11. Counter CM, Hirte HW, Bacchetti S and Harley CB: Telomerase activity in human ovarian carcinoma. Proc Natl Acad Sci USA 91: 2900-2904, 1994.
12. Counter CM, Avilion AA, LeFeuvre CE, Stewart NG, Greider CW, Harley CB and Bacchetti S: Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 11: 1921-1929, 1992.
13. Nakamura TM, Morin GB, Chapman KB, Weinrich SL, Andrews WH, Lingner J, Harley CB and Cech TR: Telomerase catalytic subunit homologs from fission yeast and human. Science 277: 955-959, 1997.
14. Feng JW, Funk D, Wang S-S, Weinrich SL, Avilion AA, Chiu C-P, Adams RR, Chang E, Allsopp RC, Yu J, Le S, West MD, Harley CB, Andrews WH, Greider CW and Villeponteau B: The RNA component of human telomerase. Science 269: 1236-1241, 1995.
15. Collins K, Kobayashi R and Greider CW: Purification of Tetrahymena telomerase and cloning of genes encoding the two protein components of the enzyme. Cell 81: 677-686, 1995.
16. Harrington L, McPhail T, Mar V, Zhou W, Oulton R, Amgen EST Program, Bass MB, Arruda I and Robinson MO: A mammalian-telomerase-associated protein. Science 175: 973-976, 1997.
17. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PLC, Coviello GM, Wright WE, Weinrich SL and Shay JW: Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011-2015, 1994.
18. Tahara H, Nakanishi T, Kitamoto M, Nakashio R, Shay JW, Tahara E, Kajiyama G and Ide T: Telomerase activity in human liver tissues: comparison between liver disease and hepatocellular carcinomas. Cancer Res 55: 2734-2736, 1995.
19. Hiyama K, Hiyama E, Ishoka S, Yamakido M, Inai K, Gazdar AF, Piatyszek MA and Shay JW: Telomerase activity in small-cell and non-small-cell lung cancers. J Natl Cancer Instit 87: 895-902, 1995.
20. Nilsson P, Mehle C, Remes K and Roos G. Telomerase activity in vivo in human malignant hematopoietic cells. Oncogene 9: 3043-3048, 1994.
21. Broccoli D, Young JW and de Lange T: Telomerase activity in normal and malignant hematopoietic cells. Proc Natl Acad Sci USA 92: 9082-9086, 1995.
22. Norrback K-F, Dahlenborg K, Carlsson R and Roos G: Telomerase activation in normal B lymphocytes and Non-Hodgkin's lymphomas. Blood 88: 222-229, 1996.
23. Hiyama K, Hirai Y, Kyoizumi S, Akiyama M, Hiyama E, Piatszek MA, Shay JW, Ishioka S and Yamakido M: Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 155: 3711-3715, 1995.
24. Yui J, Shui C-P and Lansdorp PM: Telomerase activity in candidate stem cell from fetal liver and adult bone marrow. Blood 91: 3255-3262, 1998.
25. Chiu C-P, Dragowska W, Kim NW, Vaziri H, Yui J, Thomas TE, Harley CB and Lansdorp PM: Differential expression of telomerase activity in hematopoietic progenitors from adult human bone marrow. Stem Cells 2: 239-248, 1996.
26. Counter CM, Gupta J, Harley CB, Leber B and Bacchetti S: Telomerase activity in normal leukocytes and in hematologic malignancies. Blood 85: 2315-2320, 1995.
27. Igarashi H and Sakaguchi N: Telomerase activity is induced by the stimulation to antigen receptor in human peripheral lymphocytes. Biochem Biophys Res Comm 219: 649-655, 1996.
28. Weng N-P, Levine BL, June CH and Hodes RJ: Regulated expression of telomerase activity in human T lymphocyte development and activation. J Exp Med 183: 2471-2479, 1996.
29. Yamada O, Motoji T and Mizoguchi H: Up-regulation of telomerase activity in human lymphocytes. Biochem Biophy Acta 1314: 260-266, 1996.
30. Buchkovich KJ and Grieder CW: Telomerase regulation during entry into the cell cycle in normal human T cells. Mol Biol Cell 7: 1443-1454, 1996.
31. Ogoshi M, Takashima A and Taylor RS: Mechanisms regulating telomerase activity in murine Tcells. J Immunol 158: 622-628, 1997.
32. Vaziri H, Dragowska W, Allsopp RC, Thomas TE, Harley CB and Landorp PM: Evidence for a mitotic clock in human hematopoietic stem cell: loss of telomeric DNA with age. Proc Natl Acad Sci USA 91: 9857-9860, 1994.
33. Weng N-P, Levine BL, June CH and Hodes RJ: Human naive and memory T lymphocytes differ in telomeric length and replicative potential. Proc Natl Acad Sci USA 92: 11091-11094, 1995.
34. Weng N-P, Palmer LD, Levine BL, Lane HC, June CH and Hodes RJ: Tales of tails: regulation of telomere length and telomerase activity during lymphocyte development, differentiation, activation, and aging. Immunol Rev 160: 43-54, 1997.
35. Strahl C and Blackburn EH: The effects of nucleoside analogs on telomerase and telomeres in Tetrahymena. Nucl Acids Res 22: 893-900, 1994.
36. Strahl C and Blackburn EH: Effects of reverse transcriptase inhibitors on telomere length and telomerase activity in two immortalized human cell lines. Mol Cell Biol 16: 53-65, 1996.
37. Raymond E, Sun D, Chen S-F, Windle B and Von Hoff DD: Agents that target telomerase and telomeres. Curr Opinion in Biotechnol 7, 583-591, 1996.
38. Yegorov YE, Chernov DN, Akimov SS, Bolsheva NL, Krayevsky AA and Zelenin AV: Reverse transcriptase inhibitors suppress telomerase function and induce senescence-like processes in cultured mouse fibroblasts. FEBS Letters 389: 115-118, 1996.
39. Sharma S, Raymond E, Soda H, Sun D, Hilsenbeck SG, Sharma A, Izbicka E, Windle B and Von Hoff DD: Preclinical and clinical strategies for development of telomerase and telomere inhibitors. Ann Oncol 8: 1063-1074, 1997.
40. Joshi SS, Palen BN, Mata JE and Iverson PL. Growth inhibitory effects of telomere mimic oligonucleotides on human leukemia/ lymphoma cells in vitro [abstract]. Proc Amer Assoc Cancer Res 36: 411, 1995.
41. Ohnuma T, Li F-L and Holland J: Inhibitory effects of telomere-mimic phosphorothioate oligonucleotides on various human tumor cells in vitro. Anticancer Res 17: 2445-2458, 1997.
42. Mata JE, Joshi SS, Palen B, Pirruccello SJ, Jackson JD, Elias N, Page TD, Medlin KL and Iverson PL: A hexameric phosphorothioate oligonucleotide telomerase inhibitor arrests growth of Burkitt's lymphoma cells in vitro and in vivo. Toxicol Appl Pharmicol 144: 189-197, 1997.